Serious neurological conditions following pertussis immunization: An analysis of endotoxin levels, the vaccine adverse events reporting system (VAERS) database and literature review

Pediatric Rehabilitation

Volumn 5, Issue 3, 2002, Pages 177-182

  Geier, David A ^a   Geier, Mark R ^b  

^a MedCon Inc   (United States)

^b Genetic Centers of America   (United States)

Author keywords

Acellular DTaP; Brain damage; Death; VAERS; Whole cell DTP

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; ENDOTOXIN;

ARTICLE; BRAIN DISEASE; BRAIN INJURY; CHILD; DATA BASE; DEATH; HUMAN; IMMUNIZATION; INCIDENCE; INFANTILE SPASM; LIMULUS LYSATE TEST; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEIZURE; TOXIN ANALYSIS;

CHILD; DATABASES, FACTUAL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; ENDOTOXINS; HUMANS; NERVOUS SYSTEM DISEASES; PRODUCT SURVEILLANCE, POSTMARKETING; RISK ASSESSMENT; VACCINES, ACELLULAR;

EID: 0036664977     PISSN: 13638491     EISSN: None     Source Type: Journal    
DOI: 10.1080/1363849021000054031     Document Type: Article

References (23)

1. GEIER, D. A. and GEIER, M. R.: The true story of pertussis vaccination: a sordid legacy? Journal of Histology Medicine in Allied Science, 57: 249-284, 2002.
2. GEIER, M. R., STANBRO, H. and MERRIL, C. R.: Endotoxins in commercial vaccines. Applied Environmental Biology, 36: 445-449, 1978.
3. SINGLETON, J. A., LLOYD, J. C., MOOTREY, G. T. et al.: An overview of the vaccine adverse events reporting system (VAERS) as a surveillance system. Vaccine, 17: 2908-2917, 1999.
4. GEIER, D. A. and GEIER, M. R.: The VAERS and CDC Reportable Disease databases are new tools for those in vaccine related forensic medicine. A case in point: adult hepatitis B vaccine. The Forensic Examiner, 11: 21-29, 2002.
5. GEIER, M. R. and GEIER, D. A.: Arthritic reactions and hepatitis B vaccination: an analysis of the vaccine adverse events reporting system (VAERS) from 1990 through 1997 (letter). Clinical and Experimental Rheumatology, 18: 789-790, 2000.
6. GEIER, M. R. and GEIER, D. A.: Immunological reactions and hepatitis B vaccine (letter). Annals of Internal Medicine, 134: 1155, 2001.
7. GEIER, D. A. and GEIER, M. R.: Hepatitis B vaccination and adult associated gastrointestinal reactions: a followup analysis. Hepatogastroenterology, 49: 1571-1575, 2002.
8. GEIER, D. A. and GEIER, M. R.: Hepatitis B vaccination and arthritic adverse reactions: a followup analysis of the vaccine adverse events reporting system (VAERS) database (letter). Clinical and Experimental Rheumatology, 20: 119, 2002.
9. GEIER, D. A. and GEIER, M. R.: Cutaneous immunological reactions to hepatitis B virus vaccine (letter). Annals of Internal Medicine, 136: 780-781, 2002.
10. GEIER, M. R. and GEIER, D. A.: Hepatitis B vaccination safety. Annals of Pharmacotherapy, 36: 370-374, 2002.
11. GEIER, D. A. and GEIER, M. R.: An analysis of the occurrence of convulsions and death after childhood vaccination. Toxicology Mechanisms and Methods, 12: 71-78, 2002.
12. GEIER, D. A. and GEIER, M. R.: An analysis of the reactivity of vaccines administered in the state of Texas from 1991 through 1999. Texas Medicine, 98: 50-54, 2002.
13. GEIER, D. A. and GEIER, M. R.: Rubella vaccine and arthritic adverse reactions: an analysis of the vaccine adverse events reporting system (VAERS) database from 1991 through 1998. Clinical and Experimental Rheumatology, 19: 724-726, 2001.
14. GEIER, D. A. and GEIER, M. R.: Anthrax vaccination and joint related adverse reactions in light of biological warfare scenarios. Clinical and Experimental Rheumatology, 20: 217-220, 2002.
15. OLIN, P., RASMUSSEN, F., GUSTAFSSON, L. et al.: Randomized controlled trial of two-component, three component, and five component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Lancet, 350: 1569-1577, 1997.
16. KUNO-SAKI, H. and KIMURA, M.: Epidemiology of pertussis and use of acellular pertussis vaccines in Japan. Developments in Biology Standards, 89: 331-332, 1997.
17. ECKMAN, P. L.: Studies on the blood brain barrier. American Journal of Pathology, 34: 631-643, 1958.
18. IWASA, S., ISHIDA, K. and AKUMAI K.: Swelling in the brain in mice caused by pertussis vaccine - its quantitative determination and the responsible factors in the vaccine. Japan Journal of Medical Science and Biology, 38: 53-65, 1985.
19. HOMMA, R., KURATSUKA, K., SHIMAZAKI, Y. et al.: The partial purification and some biological activities of histamine sensitizing factor from Bordetella pertussis. Symposium, 23: 277-281, 1970.
20. BERGMAN, R. K. and MUNOZ, J. J.: Effect of Bordetella pertussis extract and vasoactive amines on vascular permeability. Journal of Allergy Clinical Immunology, 55: 378-385, 1975.
21. LINTHICUM, D. S., MUNOZ, J. J. and BLASKETT, A.: Acute experimental autoimmune encephalomyelitis in mice. Cell Immunology, 73: 299-310, 1982.
22. SIDEY, F. M., FURMAN, B. L. and WARDLAW, A. C.: Effect of hyperreactivity to endotoxin on the toxicity of pertussis vaccine and pertussis toxins in mice. Vaccine, 7: 237-241, 1989.
23. GEIER, M. R. and GEIER, D. A.: Reply: clinical implications of endotoxin concentrations in vaccines (letter). Annals of Pharmacotherapy, 36: 1550-1561, 2002.